Incidence, diagnosis and pathophysiology of amniotic fluid embolism

References

• Ahmed M, Abdullatif M. 2011. Fetomaternal transfusion as a cause of severe fetal anemia causing early neonatal death: a case report. Oman Medical Journal 26:444–446.
   PubMedGoogle Scholar
• Attwood HD. 1956. Fatal pulmonary embolism by amniotic fluid. Journal of Clinical Pathology 9:38–46.
   PubMedGoogle Scholar
• Benson MD. 1993. Nonfatal amniotic fluid embolism. Three possible cases and a new clinical definition. Archives of Family Medicine 2:989–994.
   PubMedGoogle Scholar
• Benson MD. 2012. Current concepts of immunology and diagnosis in amniotic fluid embolism. Clinical and Developmental Immunology 2012:946576.
   PubMedGoogle Scholar
• Benson MD, Cheema N, Kaufman MW, Goldschmidt RA, Beaumont JL. 2012. Uterine intravascular fetal material and coagulopathy at peripartum hysterectomy. Gynecologic and Obstetric Investigation 73:158–161.
   PubMedGoogle Scholar
• Benson MD, Kobayashi H, Silver RK, Oi H, Greenberger PA, Terao T. 2001. Immunologic studies in presumed amniotic fluid embolism. Obstetrics and Gynecology 97:510–514.
   PubMed Web of Science ®Google Scholar
• Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF. 1995. Amniotic fluid embolism: analysis of the national registry. American Journal of Obstetrics and Gynecology 172:1158–1167.
   PubMed Web of Science ®Google Scholar
• Clark SL, Pavlova Z, Greenspoon J, Horenstein J, Phelan JP. 1986. Squamous cells in the maternal pulmonary circulation. American Journal of Obstetrics and Gynecology 154:104–106.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Romero R. 2009. Amniotic fluid embolism: an evidence-based review. American Journal of Obstetrics and Gynecology 201:445.e1–13.
   Google Scholar
• del Balzo U, Polley MJ, Levi R. 1989. Cardiac anaphylaxis. Complement activation as an amplification system. Circulation Research 65:847–857.
   PubMedGoogle Scholar
• Fineschi V, Gambassi R, Gherardi M, Turillazzi E. 1998. The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase. International Journal of Legal Medicine 111:238–243.
   PubMedGoogle Scholar
• Giampaolo C, Schneider V, Kowalski BH, Bellaver LA. 1987. The cytologic diagnosis of amniotic fluid embolism: A critical reappraisal. Diagnostic Cytopathology 3:126–128.
   PubMedGoogle Scholar
• Gist RS, Stafford IP, Leibowitz AB, Beilin Y. 2009. Amniotic fluid embolism. Anesthesia and Analgesia 108:1599–1602.
   PubMed Web of Science ®Google Scholar
• Gourley GR, Kreamer B, Arend R. 1990. Excremental studies in human neonates. Identification of zinc coproporphyrin as a marker for meconium. Gastroenterology 99:1705–1709.
   PubMed Web of Science ®Google Scholar
• Kanayama N, Inori J, Ishibashi-Ueda H, Takeuchi M, Nakayama M, Kimura S et al. 2011. Maternal death analysis from the Japanese autopsy registry for recent 16 years: significance of amniotic fluid embolism. Journal of Obstetrics and Gynaecology Research 37:58–63.
   PubMedGoogle Scholar
• Kanayama N, Yamazaki T, Naruse H, Sumimoto K, Horiuchi K, Terao T. 1992. Determining zinc coproporphyrin in maternal plasma – a new method for diagnosing amniotic fluid embolism. Clinical Chemistry 38:526–529.
   PubMed Web of Science ®Google Scholar
• Knight M, Berg C, Brocklehurst P, Kramer M, Lewis G, Oats J et al. 2012. Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BioMed Central Pregnancy and Childbirth 12:7.
   PubMed Web of Science ®Google Scholar
• Knight M, Tuffnell D, Brocklehurst P, Spark P, Kurinczuk JJ. 2010. UK Obstetric Surveillance System. Incidence and risk factors for amniotic-fluid embolism. Obstetrics and Gynecology 115:910–917.
   PubMed Web of Science ®Google Scholar
• Kobayashi H. 2012. The entry of fetal and amniotic fluid components into the uterine vessel circulation leads to sterile inflammatory processes during parturition. Frontiers in Immunology 3:321.
   PubMedGoogle Scholar
• Kobayashi H, Naruse K, Sado T, Noguchi T, Yoshida S, Shigetomi H et al. 2011. Search for amniotic fluid-specific markers: novel biomarker candidates for amniotic fluid embolism. Open Women's Health Journal 5:7–15.
   Google Scholar
• Kobayashi H, Ohi H, Terao T. 1993. A simple, noninvasive, sensitive method for diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2–6GalNAc. American Journal of Obstetrics and Gynecology 168:848–853.
   PubMed Web of Science ®Google Scholar
• Kobayashi T. 2010. [Amniotic fluid embolism-induced disseminated intravascular coagulation]. Acta Obstetrica et Gynaecologica Japonica 62:262–266.
   Google Scholar
• Kramer MS, Rouleau J, Liu S, Bartholomew S, Joseph KS. 2012. Maternal Health Study Group of the Canadian Perinatal Surveillance System. Amniotic fluid embolism: incidence, risk factors, and impact on perinatal outcome. British Journal of Obstetrics and Gynaecology 119:874–879.
   Google Scholar
• Kuhlman K, Hidvegi D, Tamura RK, Depp R. 1985. Is amniotic fluid material in the central circulation of peripartum patients pathologic?American Journal of Perinatology 2:295–299.
   PubMedGoogle Scholar
• Leong AS, Norman JE, Smith R. 2008. Vascular and myometrial changes in the human uterus at term. Reproductive Sciences 15:59–65.
   PubMedGoogle Scholar
• Moore J, Baldisseri MR. 2005. Amniotic fluid embolism. Critical Care Medicine 33:S279–S285.
   PubMedGoogle Scholar
• Mulder JI. 1985. Amniotic fluid embolism: an overview and case report. American Journal of Obstetrics and Gynecology 152:430–435.
   PubMedGoogle Scholar
• Naruse K, Noguchi T, Yoshida S, Tsunemi T, Shigetomi H, Oi H et al. 2012. Identification of interleukin-6 (IL-6) and squamous cell carcinoma (SCC) as amniotic fluid-specific markers. Open Journal of Obstetrics and Gynecology 2:147–150.
   Google Scholar
• Nishio H, Matsui K, Miyazaki T, et al. 2002. A fatal case of amniotic fluid embolism with elevation of serum mast cell tryptase. Forensic Science International 126:53–56.
   PubMed Web of Science ®Google Scholar
• Oi H, Naruse K, Noguchi T, Sado T, Kimura S, Kanayama N et al. 2010. Fatal factors of clinical manifestations and laboratory testing in patients with amniotic fluid embolism. Gynecologic and Obstetric Investigation 70:138–144.
   PubMedGoogle Scholar
• O’Shea A, Eappen S. 2007. Amniotic fluid embolism. International Anesthesiology Clinics 45:17–28.
   PubMedGoogle Scholar
• Roberts CL, Algert CS, Knight M, Morris JM. 2010. Amniotic fluid embolism in an Australian population-based cohort. British Journal of Obstetrics and Gynaecology 117:1417–1421.
   Google Scholar
• Rudra A, Chatterjee S, Sengupta S, Nandi B, Mitra J. 2009. Amniotic fluid embolism. Indian Society of Critical Care Medicine 13:129–135.
   PubMedGoogle Scholar
• Stolk KH, Zwart JJ, Schutte J, VAN Roosmalen J. 2012. Severe maternal morbidity and mortality from amniotic fluid embolism in the Netherlands. Acta Obstetricia et Gynecologica Scandinavica 91:991–995.
   PubMedGoogle Scholar
• Szebeni J, Baranyi L, Sávay S, Bodó M, Milosevits J, Alving CR et al. 2006. Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function. American Journal of Physiology. Heart and Circulatory Physiology 290:H1050–H1058.
   PubMed Web of Science ®Google Scholar
• Tsunemi T, Oi H, Sado T, Naruse K, Noguchi T, Kobayashi H. 2012. An overview of amniotic fluid embolism: past, present and future directions. Open Women's Health Journal 6:24–29.
   Google Scholar
• Tuffnell DJ. 2005. United Kingdom amniotic fluid embolism register. British Journal of Obstetrics and Gynaecology 112:1625–1629.
   Google Scholar
• Vercellotti GM, Hammerschmidt DE, Craddock PR, Jacob HS. 1982. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis. Blood 59: 1299–1304.
   PubMed Web of Science ®Google Scholar